Delivery Order SPE2DB24D2013-SPE2DB25FCHZG
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,937.65 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination respiratory medication, with a completion date of August 26, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs across military and...
- The Defense Logistics Agency awarded a delivery order valued at $1,729.62 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination respiratory medication, with an ultimate completion date of April 23, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a child contract under a larger vehicle. The award was made to AmerisourceBergen's Corporate Office division, headquartered in Conshohocken, Pennsylvania, which serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $14,902.03 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination respiratory medication, with an ultimate completion date of October 29, 2025. This is a firm fixed-price, non-set-aside contract executed on October 28, 2025, with performance at the company's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $6,846.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination respiratory medication, with performance in Conshohocken, Pennsylvania and completion targeted for November 13, 2025. This delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $1,855.39 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination respiratory medication supplied in a 60-dose inhaler. The contract, awarded on October 31, 2025, with completion targeted for November 3, 2025, was competitively awarded with no set-aside designation. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order valued at $6,025.10 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination respiratory medication, with an ultimate completion date of July 11, 2025. This competitively awarded, firm fixed price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical supply transaction supporting federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $13,326.39 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a respiratory maintenance medication supplied in a 60-dose package. This competitive, non-set-aside contract award was issued on September 3, 2025, with an ultimate completion date of September 4, 2025, reflecting a rapid fulfillment timeline typical of pharmaceutical supply orders. The contract employs firm fixed pricing and will be performed at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,378.41 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination respiratory medication, with an ultimate completion date of September 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively on September 19, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the performing location and is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $41,151.87 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination respiratory medication, with delivery required by September 25, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation to support federal pharmaceutical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $2,658.71 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a respiratory maintenance medication supplied in a 60-dose inhaler configuration. Awarded on July 21, 2025, with completion targeted for July 22, 2025, this firm fixed-price delivery order was competitively awarded with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- SPE2DB24D2013Indefinite Delivery Contract
- SPE2DB24D2013-SPE2DB25FCHZGDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $27,388.32 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination respiratory medication, with a completion date of April 25, 2025. This competitively awarded, firm fixed-price delivery order was issued under no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has established itself as a critical vendor within the federal medical procurement ecosystem, particularly supporting military and veteran healthcare systems. This delivery order represents a continuation of AmerisourceBergen Drug Corp's substantial role within the Defense Logistics Agency's pharmaceutical supply chain. The award is a child contract issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. The IDC enables the company to supply a diverse range of pharmaceutical products and medical supplies to military healthcare programs worldwide, supporting customers including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen as a key component of federal medical logistics operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.4k | 4/24/25 |